These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21378502)

  • 1. Low cytosine triphosphate synthase 2 expression renders resistance to 5-fluorouracil in colorectal cancer.
    Tan WL; Bhattacharya B; Loh M; Balasubramanian I; Akram M; Dong D; Wong L; Thakkar B; Salto-Tellez M; Soo RA; Fichtner I; Iacopetta B; Soong R
    Cancer Biol Ther; 2011 Mar; 11(6):599-608. PubMed ID: 21378502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling.
    Petty RD; Samuel LM; Murray GI; MacDonald G; O'Kelly T; Loudon M; Binnie N; Aly E; McKinlay A; Wang W; Gilbert F; Semple S; Collie-Duguid ES
    BMC Cancer; 2009 Dec; 9():434. PubMed ID: 20003335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer.
    Zhao Y; Wang C; Goel A
    Carcinogenesis; 2021 Jun; 42(6):814-825. PubMed ID: 33822896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
    Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
    Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined therapy with a thymidylate synthase-inhibiting vector and S-1 has effective antitumor activity against 5-FU-resistant tumors.
    Kadota K; Huang CL; Liu D; Yokomise H; Haba R; Wada H
    Int J Oncol; 2011 Feb; 38(2):355-63. PubMed ID: 21174056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the role of nucleoside transporters in the resistance of colorectal cancer to 5-fluorouracil therapy.
    Phua LC; Mal M; Koh PK; Cheah PY; Chan EC; Ho HK
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):817-23. PubMed ID: 23271323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NF‑κB signaling pathway.
    Wang Z; Zhao X; Wang W; Liu Y; Li Y; Gao J; Wang C; Zhou M; Liu R; Xu G; Zhou Q
    Int J Oncol; 2018 Nov; 53(5):2102-2110. PubMed ID: 30106136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal imbalance maps of human 5FU-resistant colorectal cancer cell lines: implications in the analysis of 5FU-acquired resistance mechanisms.
    Plasencia C; Rooney PH; Taron M; Martinez-Balibrea E; McLeod HL; Abad A
    Int J Oncol; 2003 May; 22(5):945-53. PubMed ID: 12684658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-fluorouracil (5FU) treatment does not influence invasion and metastasis in microsatellite unstable (MSI-H) colorectal cancer.
    Warusavitarne J; Ramanathan P; Kaufman A; Robinson BG; Schnitzler M
    Int J Colorectal Dis; 2006 Oct; 21(7):625-31. PubMed ID: 16557375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEACAM1 and hollow spheroid formation modulate the chemosensitivity of colorectal cancer to 5-fluorouracil.
    Yamamoto N; Yokoyama S; Ieda J; Mitani Y; Yamaguchi S; Takifuji K; Hotta T; Matsuda K; Watanabe T; Shively JE; Yamaue H
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):421-30. PubMed ID: 25547406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of smart solid lipid nanoparticles to enhance the efficacy of 5-fluorouracil in the treatment of colorectal cancer.
    Smith T; Affram K; Nottingham EL; Han B; Amissah F; Krishnan S; Trevino J; Agyare E
    Sci Rep; 2020 Oct; 10(1):16989. PubMed ID: 33046724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
    Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
    Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Casein Kinase 2α Enhances 5-Fluorouracil Resistance in Colorectal Cancer Cells by Inhibiting Endoplasmic Reticulum Stress.
    Kim HJ; Han YS; Lee JH; Lee SH
    Anticancer Res; 2020 Mar; 40(3):1419-1426. PubMed ID: 32132038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of long non‑coding RNA PVT1 reverses multidrug resistance in colorectal cancer cells.
    Fan H; Zhu JH; Yao XQ
    Mol Med Rep; 2018 Jun; 17(6):8309-8315. PubMed ID: 29693171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Transcriptomic Biomarkers of 5-Fluorouracil Resistance.
    Fekete JT; Győrffy B
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
    Xu F; Ye ML; Zhang YP; Li WJ; Li MT; Wang HZ; Qiu X; Xu Y; Yin JW; Hu Q; Wei WH; Chang Y; Liu L; Zhao Q
    Cancer Sci; 2020 May; 111(5):1528-1541. PubMed ID: 32073706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative effects of ZD0473 (AMD473) in combination with 5-fluorouracil or SN38 in human colorectal cancer cell lines.
    Plasencia C; Abad A; Martinez-Balibrea E; Taron M
    Invest New Drugs; 2004 Nov; 22(4):399-409. PubMed ID: 15292710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy.
    Grassilli E; Narloch R; Federzoni E; Ianzano L; Pisano F; Giovannoni R; Romano G; Masiero L; Leone BE; Bonin S; Donada M; Stanta G; Helin K; Lavitrano M
    Clin Cancer Res; 2013 Jul; 19(14):3820-31. PubMed ID: 23729362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Expression of ERCC6 Confers Resistance to 5-Fluorouracil and Is Associated with Poor Patient Survival in Colorectal Cancer.
    Zhao Z; Zhang G; Li W
    DNA Cell Biol; 2017 Sep; 36(9):781-786. PubMed ID: 28665687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma.
    Li M; Xia M; Zhang Z; Tan Y; Li E; Guo Z; Fang M; Zhu Y; Hu Z
    Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35856434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.